speaker-icon

Latest Posts

Partex-NV-announces-collaboration-with-Althea-DRF-Lifesciences

28

Mar 24

Partex NV announces collaboration with Althea DRF Lifesciences to provide comprehensive end-to-end services to accelerate drug discovery and development

Frankfurt, Germany; 28 March 2024 – Partex Group, a pioneer in AI-driven drug discovery, announces a collaboration with Althea DRF...
Read More
Partex-Group-presents-results-from-a-pilot-project-with-AIO

18

Mar 24

Innovative AI technology in oncology: Partex Group presents results from a pilot project

During the German Cancer Congress 2024 in Berlin, the companies Innoplexus AG /Amrit AG, companies of Partex N.V., presented the...
Read More

Innoplexus wins Horizon Interactive Gold Award for Curia App

Read More

Archives: News

accelerating-innovation

Accelerating innovation in Pharma with Artificial Intelligence & Big Data

As Kevin Rands, (a contributor at CIO.com) has stated in his blog “Data is the lifeline of any business”, and truly said, it remains the heart of businesses for life sciences and pharmaceutical industries. A lot still relies upon data while conducting research which is mostly done through traditional methods. As many top notch business …

Accelerating innovation in Pharma with Artificial Intelligence & Big Data Read More »

proudly-announces

Innoplexus Proudly Announces the Launch of its Product iPlexus, at Bio-IT World, 2017

Innoplexus unveiled iPlexus at Bio-IT, 2017, Boston. iPlexus.ai is an end-to-end platform for Life Sciences which leverages Artificial Intelligence (AI) to cut the drug development time, from synthesis to approval, significantly. It generates continuous intelligence and insights, across discovery, clinical development, regulatory and commercial stages of drug development, spanning all major therapeutic areas and indications. …

Innoplexus Proudly Announces the Launch of its Product iPlexus, at Bio-IT World, 2017 Read More »

innoplexus-featured

Innoplexus featured on Inc.

3 Ways Big Data and Analytics are Making Big Changes in Healthcare The technologies behind the next wave in healthcare innovation. Information is the new currency of innovation. With data flowing from countless new sources every day, the opportunities to dig in and learn more about the world around us have never been greater. Sometimes …

Innoplexus featured on Inc. Read More »

bio-it-world

Innoplexus at Bio-IT World

Excited to announce that Innoplexus is a gold sponsor of Bio-IT World Conference & Expo which is a 3 day event being held from 23rd May to 25th May 2017 at the Seaport World Trade Center in Boston, United States Of America. This event will feature various sectors from the Bioinformatics industry. Our Founder and …

Innoplexus at Bio-IT World Read More »

innoplexus-featured-dataquest

Innoplexus Featured in DataQuest

Innoplexus launches iPlexus to transform decision support in the Life Sciences Industry Innoplexus, the technology and product development company focused on AI and advanced analytics, announced the launch of its product iPlexus, an end to end platform for Life Sciences which leverages artificial intelligence to generate continuous intelligence and insights across discovery, clinical development, regulatory …

Innoplexus Featured in DataQuest Read More »

innoplexus-sign

Innoplexus signs MoU to provide academic license for its iPlexus platform to Regional Cancer Centre, Gwalior, India

Innoplexus is proud to announce our collaboration with the Regional Cancer Centre, Gwalior. Innoplexus has executed an MoU to provide an academic license for its iPlexus platform to RCC, Gwalior, India. The academic license allows doctors and researchers with free access to iPlexus. Doctors and researchers will be able to gain insights into the latest …

Innoplexus signs MoU to provide academic license for its iPlexus platform to Regional Cancer Centre, Gwalior, India Read More »

German VC firm invests in Data as a Service startup Innoplexus

German VC firm invests in Data as a Service startup Innoplexus

Innoplexus, a Germany- and India-based Data as a Service (DaaS) startup, has closed an undisclosed sum in pre-Series A funding from HCS, a Germany-based Venture VC firm. With the capital, the startup plans to file more patent applications, further develop its trademark platform iPlexus, and invest in marketing.